InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
5
Disclosed sells
0
T+90 hit rate
30%
T+90 mean return
+1.2%
Across 20 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Clemmer James C, Chairman & CEO. Insider active across 1 company, notably Angiodynamics INC. Cumulatively, 33 reports have been logged. Breakdown: 5 buys · 0 sell. Total volume traded: €729k. History available since 14 July 2021. The latest transaction was filed on 20 July 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations33 total
344 shares@ US$8.690.2% of flowCommon StockSEC:0001140361-25-026797:0
8,307 shares@ US$8.694.7% of flowCommon StockSEC:0001140361-25-026797:1
2,982 shares@ US$8.691.7% of flowCommon StockSEC:0001140361-25-026797:2
3,673 shares@ US$8.992.1% of flowCommon StockSEC:0001140361-25-026797:3
20,000 shares@ US$6.038.3% of flowCommon StockSEC:0001140361-24-043157:0
Ideal exit: 4 Jul 2025 (T+270)
56,279 shares0Common StockSEC:0001140361-24-035600:0
2,982 shares@ US$7.131.5% of flowCommon StockSEC:0001140361-24-034270:0
8,307 shares@ US$7.184.1% of flowCommon StockSEC:0001140361-24-033784:0
3,817 shares0Common StockSEC:0001140361-24-033912:0
105,811 shares0Common StockSEC:0001140361-24-033635:0
10,000 shares@ US$6.704.6% of flowCommon StockSEC:0001140361-24-018620:0
Ideal exit: 3 Jan 2025 (T+270)
69,676 shares0Common StockSEC:0001140361-23-044830:0
31,572 shares0Common StockSEC:0001140361-23-036322:0
2,982 shares@ US$8.741.8% of flowCommon StockSEC:0001140361-23-036120:0
3,372 shares@ US$8.652.0% of flowCommon StockSEC:0001140361-23-036120:1
92,181 shares0Common StockSEC:0001140361-23-035729:0
4,906 shares@ US$9.633.2% of flowCommon StockSEC:0001140361-23-035086:0
2,262 shares@ US$9.561.4% of flowCommon StockSEC:0001140361-23-035086:1
10,000 shares@ US$15.0011.6% of flowCommon StockSEC:0001567619-22-018410:0
Ideal exit: 7 Jul 2023 (T+270)
33,094 shares0Common StockSEC:0001567619-22-014379:0
25,123 shares0Common StockSEC:0001567619-22-013842:0
10,000 shares@ US$22.8415.2% of flowCommon StockSEC:0001567619-22-001113
Ideal exit: 8 Oct 2022 (T+270)
10,000 shares@ US$22.840.045% mcap28.7% of flowCommon StockSEC:0001567619-22-001113:0
Ideal exit: 8 Oct 2022 (T+270)
37,420 shares0Common StockSEC:0001567619-21-022713
37,420 shares0Common StockSEC:0001567619-21-022713:0
25 of 33 declarations
About Clemmer James C
James C. Clemmer is the President and CEO of ANGIODYNAMICS INC. He leads the company by implementing strategies to enhance performance and achieve growth objectives. His leadership is essential for the development of innovative products and market expansion.
